U.S. Leisure Stock News

Arbor Realty Trust (ABR) has wrapped up FY 2025 with fourth quarter revenue of US$158.9 million and basic EPS of US$0.07, setting the stage for investors to reassess how the income story lines up with the stock’s US$8.17 share price. Over the past six quarters, reported revenue has moved between US$111.1 million and US$166.5 million while quarterly basic EPS has ranged from US$0.07 to US$0.32, giving you a clear view of how the top line and per share earnings have tracked through recent...

Coinbase Global (COIN) has wrapped up FY 2025 with a wide range of quarterly outcomes, including Q4 revenue of US$1.7b and a basic EPS loss of US$2.49, alongside a trailing twelve month EPS of US$4.85 on revenue of US$6.9b. Over the last six reported quarters, revenue has moved between US$1.1b and US$2.2b while quarterly basic EPS has swung from a loss of US$2.49 to a profit of US$5.60, underlining how sensitive results have been to market conditions and trading activity. For investors, the...

Sumitomo Mitsui Financial Group has acquired a significant stake in Jefferies Financial Group (NYSE:JEF) through open market purchases. The deal includes a board seat for Sumitomo Mitsui Financial Group's Deputy President at Jefferies. This move deepens an existing partnership between the two financial companies. Jefferies Financial Group runs a global investment banking and capital markets business, an area where scale, distribution, and relationships can matter for winning mandates. Large...

Sylvamo (SLVM) closed FY 2025 with Q4 revenue of US$890 million and basic EPS of US$0.84, while net income excluding extra items came in at US$33 million, setting the tone for how investors may read the full year. The company has seen quarterly revenue range from US$794 million to US$890 million over FY 2025, with basic EPS moving between roughly US$0.37 and US$1.43 and trailing 12 month EPS reported at US$3.29. The latest figures therefore sit within a year of mixed earnings power and...

Mitek Systems (MITK) opened Q1 2026 with total revenue of US$44.2 million and basic EPS of US$0.06, setting a clear marker for how the year is starting to shape up after a period of sharp reported earnings growth over the past 12 months. The company has seen trailing twelve month revenue move from US$172.1 million in Q4 2024 to US$186.7 million in Q1 2026, with trailing EPS over the same window rising from US$0.07 to US$0.35, putting more weight behind the recent improvement in profitability...

Lexicon Pharmaceuticals (LXRX) just closed FY 2025 with fourth quarter revenue of US$5.5 million and a basic EPS loss of US$0.04, alongside net income losses of US$15.5 million, keeping the focus squarely on how quickly the top line can scale against persistent red ink. The company has seen quarterly revenue move from US$26.6 million in Q4 2024 to US$5.5 million in Q4 2025, with EPS shifting from a loss of US$0.09 to a loss of US$0.04 over the same periods. Trailing 12 month revenue stands at...

ZipRecruiter (ZIP) just posted its FY 2025 numbers with Q4 revenue of US$111.7 million and a basic EPS loss of US$0.01, while the trailing 12 month figures show revenue of US$449.0 million and a basic EPS loss of US$0.37. The company has seen recent quarterly revenue range between US$110.1 million and US$115.0 million, with basic EPS losses stretching from US$0.13 in Q1 2025 to US$0.01 in Q4 2025. This has kept the trailing year firmly in loss making territory even as forecasts point to...

Natera FY 2025 earnings snapshot Natera (NTRA) closed FY 2025 with fourth quarter revenue of US$665.5 million and basic EPS of US$0.34, as net income excluding extra items came in at US$47.3 million. The company has seen revenue move from US$476.1 million in Q4 2024 to US$665.5 million in Q4 2025, while trailing twelve month basic EPS over the same period went from a US$1.53 loss to a US$1.52 loss. This points to a story where top line scale is starting to show through in the margin...

If you are wondering whether Boise Cascade’s current share price offers good value, the recent share performance gives a useful starting point but not the full story. The stock last closed at US$72.76, with a 7 day return of 8.2% decline, a 30 day return of 2.6% decline, a year to date return of 1.8% decline, and a 1 year return of 17.9% decline, set against 3 year and 5 year returns of 14.9% and 35.5% respectively. Recent coverage has focused on Boise Cascade as part of evergreen analysis...

Expensify (EXFY) just closed FY 2025 with fourth quarter revenue of US$35.2 million, a basic EPS loss of US$0.08 per share, and a quarterly net loss of US$7.1 million. On a trailing 12 month basis, the company recorded revenue of US$142.1 million and a net loss of US$21.4 million. Over recent quarters, revenue has moved in a tight band between US$35.1 million and US$37.0 million, while quarterly basic EPS has ranged from a loss of US$0.02 to US$0.10 per share. This has left investors focused...

CareTrust REIT (CTRE) has wrapped up FY 2025 with fourth quarter revenue of US$134.9 million and basic EPS of US$0.50, setting the tone for a year where trailing twelve month revenue reached US$476.4 million and EPS came in at US$1.57. Over the past six reported quarters, revenue has moved from US$77.4 million in Q3 2024 to US$134.9 million in Q4 2025, while quarterly basic EPS has ranged from US$0.21 to US$0.50. This leaves investors focused on how these headline figures line up with the...

Alta Equipment Group (ALTG) has just posted another loss-making quarter, with Q4 FY 2025 revenue of US$509.1 million and basic EPS of a US$0.39 loss, while trailing twelve month revenue sits at US$1.84 billion and EPS at a US$2.55 loss. Over the past six reported quarters, revenue has moved within a range of US$422.6 million to US$509.1 million per quarter as losses have fluctuated between US$0.21 and US$1.31 per share, underscoring a business that is still working through margin pressure...

10x Genomics (TXG) closed out FY 2025 with Q4 revenue of US$166.0 million and a basic EPS loss of US$0.13, alongside trailing twelve month revenue of US$642.8 million and a TTM basic EPS loss of US$0.35. Over recent quarters, the company has seen revenue fluctuate between US$149.0 million and US$172.9 million, while quarterly basic EPS has moved between a loss of US$0.40 and a profit of US$0.28, highlighting an uneven path on the income line. For investors, the latest print keeps the focus on...

Arrowhead Pharmaceuticals (ARWR) opened 2026 with Q1 revenue of US$264.0 million and basic EPS of US$0.22, while trailing twelve month figures show revenue of US$1.1 billion and basic EPS of US$1.48 as the company stayed in profitable territory over the last year. Over recent quarters, revenue has moved from US$2.5 million in Q1 2025 to US$542.7 million in Q2 2025 and US$256.5 million in Q4 2025, with EPS shifting from a loss of US$1.39 per share in Q1 2025 to a profit of US$2.78 per share in...

Inseego (INSG) has wrapped up FY 2025 with fourth quarter revenue of US$48.4 million and a basic EPS loss of US$0.03, alongside net income from continuing operations of a US$0.46 million loss. Over recent quarters, the company has seen revenue move from US$31.7 million in Q1 2025 to US$45.9 million in Q3 2025 and then US$48.4 million in Q4 2025. Quarterly EPS shifted between a loss of US$0.14 in Q1 2025, a profit of US$0.03 in Q3 2025, and back to a small loss in Q4 2025. This sets up a story...

Tucows (TCX) has just wrapped up FY 2025 with Q4 revenue of about US$98.7 million and a basic EPS loss of US$1.98, alongside a Q4 net loss of US$22.0 million. Over the past six quarters, revenue has moved from US$92.3 million in Q3 2024 to US$98.7 million in Q4 2025. Quarterly basic EPS has ranged from a loss of US$3.86 in Q4 2024 to a loss of US$1.98 in the latest quarter. Trailing twelve month EPS currently sits at a loss of US$6.85 on revenue of US$390.3 million as margins remain under...

Q1 2026 earnings snapshot Natural Grocers by Vitamin Cottage (NGVC) opened fiscal 2026 with Q1 revenue of US$335.6 million and basic EPS of US$0.49, setting the tone for its latest earnings update. The company reported revenue of US$330.2 million and EPS of US$0.43 in Q1 2025, compared with US$335.6 million and EPS of US$0.49 in Q1 2026. Trailing twelve month EPS stands at US$2.08 on revenue of about US$1.3 billion, with higher net profit margins and earnings growth framing the quarter as one...

E.W. Scripps (SSP) just reported FY 2025 fourth quarter results with revenue of US$560.3 million and basic EPS of US$0.51 loss, set against a year earlier fourth quarter that showed revenue of US$728.4 million and basic EPS of US$0.93. Over recent periods the company has seen quarterly revenue move from US$646.3 million and EPS of US$0.37 in 2024 Q3 to US$560.3 million and EPS of US$0.51 loss in 2025 Q4. Trailing 12 month revenue sits at about US$2.2 billion with basic EPS of US$1.87 loss...

Cerence (CRNC) opened Q1 2026 with total revenue of US$115.1 million, Basic EPS of a US$0.12 loss, and net income excluding extra items of a US$5.2 million loss, while the trailing 12 months show Basic EPS of roughly US$0.01 and net income excluding extra items of about US$0.3 million. Over recent quarters the company has seen revenue move from US$50.9 million in Q1 2025 to US$115.1 million in Q1 2026, alongside Basic EPS shifting from a US$0.57 loss to a US$0.12 loss and trailing 12 month...

Earnings turnaround puts Mercury General in focus Mercury General (MCY) is back on many investors’ radars after first quarter results showed revenue of US$1,539.81 million and net income of US$190.42 million, compared with a net loss a year earlier. See our latest analysis for Mercury General. The earnings rebound and steady dividend news have come alongside a 1 month share price return of 8.67% and a 1 year total shareholder return of 74.37%, which together point to solid momentum rather...

If you are wondering whether Sarepta Therapeutics at US$20.80 is starting to look like value or still carries too much risk, the recent share price and fundamentals give you a lot to weigh up. The stock has been under pressure, with returns of 0.4% decline over 7 days, 9.9% decline over 30 days, 2.4% decline year to date, 43.0% decline over 1 year and 82.7% decline over 3 years, while the 5 year return sits at 71.3% decline. Recent news around Sarepta Therapeutics has focused on its position...

National Health Investors (NYSE:NHI) is selling its entire skilled nursing facility portfolio for $560 million. The company plans to redeploy proceeds into private-pay senior housing, including a seven-property portfolio in Colorado. This shift reduces exposure to skilled nursing and increases focus on private-pay assets that management views as offering more attractive risk adjusted returns. For investors watching NYSE:NHI, this move comes with the stock recently closing at $75.07 and...

Pacific Biosciences of California (PACB) has just posted its FY 2025 numbers, with Q4 revenue at US$44.6 million and a basic EPS loss of US$0.13 set against trailing twelve month revenue of US$160.0 million and a TTM basic EPS loss of US$1.82. Over the past six reported quarters, the company has seen quarterly revenue move between US$37.2 million and US$44.6 million, while basic EPS has ranged from a small profit of US$0.01 in FY 2024 Q4 to a loss of US$1.44 in FY 2025 Q1. This leaves...

Genius Sports (GENI) opened Q1 2026 with revenue of US$188 million, a basic EPS loss of US$0.21 per share, and net income loss of US$55 million, setting a cautious tone around near term profitability. The company has seen quarterly revenue move from US$144 million in Q1 2025 to US$188 million in Q1 2026, while basic EPS shifted from a loss of US$0.03 to a loss of US$0.21 over the same period. This puts the focus squarely on how efficiently that extra revenue is translating into results. For...